Home / Medroxyprogesterone / United States
US ATC G03AC06 · updated 2 Nov 2026
Medroxyprogesterone shortage in United States
Is there a Medroxyprogesterone shortage in United States?
Yes. As of 2 Nov 2026, 2 Medroxyprogesterone products are reported short in United States, the first since 31 Aug 2026. No return date has been given. Main reason: not stated.
Also short in Australia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | PROVERA, Tablet, 10 mg (NDC 0009-0051-01) discontinuation | Pfizer Inc. | 31 Aug 2026 | not given | Not stated |
| US | PROVERA, Tablet, 2.5 mg (NDC 0009-0065-01) discontinuation | Pfizer Inc. | 31 Aug 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).